Capital & FinanceEvent: September 3, 2026
BlossomHill Therapeutics, Inc. was listed on the Nasdaq Exchange.
Published
Signal category
Capital & Finance
Quote
“Our team rang the opening bell at Nasdaq Exchange today.”
— BlossomHill Therapeutics, Inc. team
Company
BlossomHill Therapeutics, Inc.
Addressing urgent unmet medical needs through deeper science, true originality, and rich experience...
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 68 employees
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders. The company is founded by renowned drug design and development scientist, J. Jean Cui, Ph.D., and biotech business veteran, Y. Peter Li, Ph.D., M.B.A. BlossomHill Therapeutics, Inc. is headquartered in San Diego, California.
Founded 2020